1. Hematology Department, Hôpital Edouard Herriot, Lyon, France;
2. Oregon Health & Science University, Knight Cancer Institute, Center for Hematologic Malignancies, Portland;
3. Molecular Biology Unit, Institute of Hematology and Medical Oncology Seràgnoli, University of Bologna, Bologna, Italy;
4. Department of Hematology, St Mary's Hospital, The Catholic University of Korea, Seoul, Korea;
5. III Medizinische Klinik, Universitätsmedizin Mannheim, Universität Heidelberg, Mannheim, Germany;
6. Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston;
7. Department of Hematology, Singapore General Hospital, Cancer & Stem Cell Biology Program, Duke-NUS Graduate Medical School, Singapore;
8. Department of Hematology, Herlev Hospital, University of Copenhagen, Herlev, Denmark;
9. Haematology Department, Hammersmith Hospital, Imperial College London, London, United Kingdom;
10. Department of Hematology, Saitama Medical University, Saitama, Japan;
11. Merck Research Laboratories, North Wales, PA;
12. Laboratory for Hematology and Molecular Biology; University Hospital of Lille, Lille, France; and
13. Cancer Therapy & Research Center at The University of Texas Health Science Center, San Antonio